Fractionated Radiation

RADIATION3 trials

Sponsors

University of Alabama at Birmingham, Zhonglin Hao, David Palma

Conditions

Esophageal CancerEsophagogastric Junction CancerGliomaMetastatic Tumor

Phase 2

ChemoRadiation And Tislelizumab for Esophageal/EGJ Cancer

WithdrawnNCT05245760

Zhonglin HaoEsophageal Cancer, Esophagogastric Junction Cancer

Start: 2022-04-30End: 2033-12-31Updated: 2022-11-08

Phase 3

A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.

RecruitingNCT05717166

David PalmaMetastatic Tumor

Start: 2023-10-06End: 2029-04-30Target: 180Updated: 2025-12-31

Unknown Phase

Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma

TerminatedNCT03168919

University of Alabama at BirminghamGlioma

Start: 2016-10-06End: 2018-06-12Updated: 2019-10-01

Related Papers

A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol

BMC Palliative Care2024-09-0710 citations